Advancing Prevention of Pulmonary Fibrosis

Active, not recruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

January 22, 2021

Primary Completion Date

August 1, 2026

Study Completion Date

August 1, 2026

Conditions
IPFPulmonary FibrosisILD
Interventions
OTHER

Sample collection

Blood, Urine, Nail, Hair, Saliva, optional Stool

OTHER

Questionnaires

SF-36, Food Frequency, Pulmonary Fibrosis Study questionnaire, COVID questionnaire

RADIATION

High resolution CT scan of the chest

Upon enrollment, all participants will undergo single prone volumetric thoracic chest CT scan. This will be performed at full inspiration using a 64-slice CT scanner.

DIAGNOSTIC_TEST

Pulmonary Function Test

All recruited participants will undergo a pre-bronchodilator spirometry test and a lung diffusion capacity test, both in accordance with ATS guidelines. Exercise capacity (maximum physical exertion) will be assessed by performing a 6-minute walk test, also according to ATS guidelines.

Trial Locations (1)

80045

University of Colorado Anschutz Medical Campus, Aurora

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mayo Clinic

OTHER

collaborator

University of California, Los Angeles

OTHER

collaborator

University of Texas

OTHER

collaborator

University of Pennsylvania

OTHER

lead

University of Colorado, Denver

OTHER